Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pieris Pharma (PIRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 314,762
  • Shares Outstanding, K 53,990
  • Annual Sales, $ 25,280 K
  • Annual Income, $ -17,650 K
  • 36-Month Beta 1.66
  • Price/Sales 12.15
  • Price/Cash Flow N/A
  • Price/Book 6.05

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.89 +27.20%
on 06/28/18
6.38 -2.51%
on 07/23/18
+1.03 (+19.85%)
since 06/22/18
3-Month
4.89 +27.20%
on 06/28/18
6.94 -10.37%
on 04/30/18
-0.14 (-2.20%)
since 04/23/18
52-Week
4.41 +40.88%
on 08/11/17
9.75 -36.21%
on 02/13/18
+0.52 (+9.12%)
since 07/21/17

Most Recent Stories

More News
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance

Loncar Investments, LLC today announced the result of the semi-annual rebalance and reconstitution of the Loncar Cancer Immunotherapy Index, a stock index of top companies developing...

CLDX : 0.51 (-1.92%)
JNCE : 7.57 (+0.13%)
IDRA : 0.88 (+2.33%)
RCUS : 11.54 (+0.70%)
BLCM : 7.16 (-3.37%)
INO : 4.31 (-0.23%)
FATE : 10.95 (+1.20%)
MRTX : 55.20 (+0.27%)
SRNE : 6.28 (+2.61%)
MOR : 35.63 (+0.85%)
AGEN : 2.06 (-2.83%)
INCY : 68.77 (-0.62%)
ZYME : 12.68 (-3.87%)
NK : 3.30 (+0.30%)
PIRS : 6.17 (+5.83%)
NLNK : 4.42 (-5.35%)
Pieris Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for cancer, respiratory and other diseases, announced...

PIRS : 6.17 (+5.83%)
Pieris Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update

COMPANY TO HOST AN INVESTOR CONFERENCE CALL ON

PIRS : 6.17 (+5.83%)
Pieris Pharmaceuticals to Present at 43rd Annual Deutsche Bank Health Care Conference

Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for cancer, respiratory and other diseases, announced...

DB : 12.14 (+0.91%)
PIRS : 6.17 (+5.83%)
Pieris Pharmaceuticals to Host First Quarter 2018 Investor Call and Corporate Update on May 10, 2018

BOSTON, MA--(Marketwired - May 01, 2018) - Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for...

PIRS : 6.17 (+5.83%)
Investor Expectations to Drive Momentum within Blackbaud, Pieris Pharmaceuticals, Sarepta Therapeutics, Cambrex, Stoneridge, and First Interstate BancSystem -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Blackbaud, Inc. (NASDAQ:BLKB),...

SRPT : 132.02 (-0.97%)
SRI : 33.61 (-0.33%)
FIBK : 43.85 (+1.62%)
BLKB : 118.15 (+0.33%)
PIRS : 6.17 (+5.83%)
CBM : 56.55 (+0.89%)
Biotech Stocks' Research Reports Released on Pieris Pharma, Portola Pharma, Protalix BioTherapeutics, and Radius Health

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on PIRS, PTLA, PLX, and RDUS which can be accessed for free by signing up to www.wallstequities.com/registration....

RDUS : 28.39 (+1.72%)
PTLA : 41.56 (+4.06%)
PIRS : 6.17 (+5.83%)
What's Happening with These Biotech Stocks? -- OncoSec Medical, OvaScience, Pacific Biosciences of California, and Pieris Pharma

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on ONCS, OVAS, PACB, and PIRS which can be accessed for free by signing up to www.wallstequities.com/registration....

PACB : 3.86 (+2.93%)
ONCS : 1.32 (unch)
OVAS : 0.89 (-3.17%)
PIRS : 6.17 (+5.83%)
Proteostasis Therapeutics (PTI) Looks Good: Stock Adds 8% in Session

Proteostasis Therapeutics (PTI) was a big mover last session, as the company saw its shares rise nearly 8% on the day amid huge volumes.

PTI : 2.76 (+1.10%)
PIRS : 6.17 (+5.83%)
Pieris Pharmaceuticals Reports Full-Year 2017 Financial Results and Corporate Update

Company to Host an Investor Conference Call on Friday, March 9, 2018 at 8:00 Am Est

PIRS : 6.17 (+5.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade PIRS with:

Business Summary

Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.

See More

Key Turning Points

2nd Resistance Point 6.06
1st Resistance Point 5.94
Last Price 6.17
1st Support Level 5.68
2nd Support Level 5.54

See More

52-Week High 9.75
Fibonacci 61.8% 7.71
Fibonacci 50% 7.08
Fibonacci 38.2% 6.45
Last Price 6.17
52-Week Low 4.41

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar